1. Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

   • H. Saxenhofer
   • P. Weidmann
   • G. Noseda

   Originals Pages: 101 - 105

2. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

   • G. F. Handeland
   • U. Abildgaard
   • K. E. Arnesen

   Originals Pages: 107 - 112

3. Effect of furosemide on angiotensin II-mediated prostaglandin I₂ production in hypertensive subjects

   • A. Fujimura
   • A. Ebihara

   Originals Pages: 113 - 115

4. Nocturnal oxygen saturation and body movement in asthmatics treated with controlled-release preparations of theophylline or terbutaline

   • P. E. Brander
   • A. R. A. Sovijärvi
   • H. Poppius

   Originals Pages: 117 - 121

5. Effects of propranolol on ventricular repolarization in man

   • K. Endresen
   • J. P. Amlie

   Originals Pages: 123 - 125

6. Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes

   • B. H. Jennings
   • K. E. Andersson
   • S. Å. Johansson

   Originals Pages: 127 - 131

7. Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women

   • C. Nappi
   • G. Colace
   • L. Annunziato

   Originals Pages: 133 - 135

8. Time course of the effect of intravenous dimetindene maleate

   • D. Rehn
   • H. Geißler
   • G. Hennings

   Originals Pages: 137 - 141

9. Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics

   • D. A. Hoffman
   • S. M. Wallace
   • R. K. Verbeeck

   Originals Pages: 143 - 148

10. Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 μG

    • M. Hildebrand
    • T. Staks
    • B. Nieuweboer

    Originals Pages: 149 - 153

11. Comparison of non-kinetic and kinetic approaches to individualization of gentamicin dosage

    • Y. M. El-Sayed
    • S. I. Islam

    Originals Pages: 155 - 159

12. Effect of age on single- and multiple-dose pharmacokinetics of erythromycin

    • P. A. Miglioli
    • P. Pivetta
    • P. Palatini

    Originals Pages: 161 - 164

13. Effect of ponsinomycin on cyclosporin pharmacokinetics

    • W. Couet
    • B. Istin
    • J. B. Fourtillan

    Originals Pages: 165 - 167

14. Medifoxamine: Oral tolerance and pharmacokinetic study in healthy human volunteers

    • S. Saleh
    • A. Johnston
    • P. Turner

    Originals Pages: 169 - 171

15. Variation of benzbromarone elimination in man — a population study

    • I. Walter-Sack
    • U. Gresser
    • N. Zöllner

    Originals Pages: 173 - 176

16. Population pharmacokinetics of phenytoin in Singapore Chinese

    • E. Chan
    • T. Y. Ti
    • H. S. Lee

    Originals Pages: 177 - 181

17. Apparent racial difference in response to angiotensin I infusion

    • P. H. Joubert
    • H. D. Brandt

    Short Communications Pages: 183 - 185

18. Dose dependent enzyme induction by oxcarbazepine?

    • P. N. Patsalos
    • J. M. Zakrzewska
    • A. A. Elyas

    Short Communications Pages: 187 - 188

19. Bioinequivalence of marketed diltiazem preparations

    • M. V. Joshi
    • P. C. Gokhale
    • N. A. Kshirsagar

    Short Communications Pages: 189 - 190

20. Pharmacokinetics of midazolam in critically ill neonates

    • E. Jacqz-Aigrain
    • C. Wood
    • I. Robieux

    Short Communications Pages: 191 - 192

21. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals

    • D. A. Sica
    • T. J. Comstock
    • G. Wright

    Short Communications Pages: 193 - 194

22. Pharmacokinetics of various single intravenous and oral doses of omeprazole

    • T. Andersson
    • C. Cederberg
    • I. Sk»nberg

    Short Communications Pages: 195 - 197

23. Chronokinetic study of netilmicin in man

    • F. Lucht
    • S. Tigaud
    • J. L. Bertrand

    Short Communications Pages: 199 - 201

24. Announcement

    Announcement Pages: 202 - 202